创模生物科技(北京)有限公司

CN / En

NEWS

InnoModels' In Vitro Killing Experimental Platform: An Innovative Tool to Uncover the Mechanisms of Cytotoxicity

  • Categories:Company news
  • Author:InnoModels
  • Origin:InnoModels
  • Time of issue:2024-04-16 14:54
  • Views:

(Summary description)With the further development of biomedicine, the study of cytotoxicity mechanism has become more and more important. In this field, the in vitro killing experiment platform of InnoModels has become an innovative tool to reveal the mechanism of cytotoxicity by virtue of its unique features

InnoModels' In Vitro Killing Experimental Platform: An Innovative Tool to Uncover the Mechanisms of Cytotoxicity

(Summary description)With the further development of biomedicine, the study of cytotoxicity mechanism has become more and more important. In this field, the in vitro killing experiment platform of InnoModels has become an innovative tool to reveal the mechanism of cytotoxicity by virtue of its unique features

  • Categories:Company news
  • Author:InnoModels
  • Origin:InnoModels
  • Time of issue:2024-04-16 14:54
  • Views:
Information

With the further development of biomedicine, the study of cytotoxicity mechanism has become more and more important. In this field, the in vitro killing experiment platform of InnoModels has become an innovative tool to reveal the mechanism of cytotoxicity by virtue of its unique features.
1. Highly simulate the real environment
The in vitro killing experimental platform of InnoModels focuses on simulating the environment of real organisms, including interactions between cells and interactions between cells and the microenvironment, etc. This high degree of simulation makes the results of the experiments more effective. This high degree of simulation makes the experimental results more credible, better reflecting the actual situation and providing more accurate data support for the study of cytotoxicity mechanism.
2、Diversified killing models
The in vitro killing experimental platform of InnoModels provides diversified killing models, including but not limited to drug killing, radiation killing, immunocide killing, etc. These models can meet different research needs, and can be used for the study of cytotoxicity. These models can meet different research needs and provide researchers with more comprehensive information on cytotoxicity mechanisms. Meanwhile, the platform also supports the customization of personalized models to meet special research needs.

 


3、High-throughput processing capability
In cytotoxicity mechanism research, a large number of samples and data need to be processed. The in vitro killing experimental platform of InnoModels Biotechnology is equipped with high-throughput processing capability, which is able to process multiple samples in a short period of time and generate experimental results quickly. This efficient processing capability not only improves research efficiency, but also provides strong support for large-scale drug screening and toxicity assessment.
4、Precise experimental control
The study of cytotoxicity mechanism requires precise experimental control to ensure the reliability of experimental results. The in vitro killing experimental platform of InnoModels adopts an advanced experimental control system, which can precisely control the experimental conditions, including the number of cells, drug concentration, treatment time and so on. This precise experimental control helps to reduce errors and improve the accuracy and reliability of experimental results.
5. Wide range of application fields
The in vitro killing experimental platform of InnoModels Biotechnology has a wide range of applications in the fields of drug research and development, toxicity assessment, and immunology research. Through this platform, researchers can gain a deeper understanding of the toxicity mechanism of drugs on cells and assess the safety of drugs; at the same time, they can also study the killing mechanism of immune cells on pathogens and provide new ideas and methods for the treatment of diseases.
In conclusion, the in vitro killing experimental platform of InnoModels Biotechnology provides powerful support for revealing the mechanism of cytotoxicity with its high simulation of the real environment, diversified killing models, high-throughput processing capability, precise experimental control, and a wide range of application areas. With the continuous progress of technology and the expansion of application fields, the platform is expected to play a greater role in biomedical research and promote the development and progress of the biomedical field.

Keyword:

In the vast field of oncology and tumor immunopharmacodynamics research, InnoModels Biotechnology (Beijing) Ltd. has become a leader in the industry with its outstanding innovation ability and profound scientific research background. This company, co-founded by scientists from Novo Nordisk China R&D Center, Sino-US Crown and Shanghai Jiao Tong University Institute of Immunology, has been committed to building a stable domestic platform of humanized mouse models of the immune system (HIS) and human tumor xenografts (PDX) since its establishment in 2020, to provide new drug discovery and development companies, translational medicine researchers, and tumor patients with new-generation laboratory animal models for new drug discovery companies, translational medicine researchers, and tumor patients
In recent years, many breakthroughs have been made in the field of biomedical research, among which iHuPBMC-T technology is undoubtedly a shining star. As an innovative platform built by InnoModels Biotechnology (Beijing) Co., Ltd, iHuPBMC-T, with its unique technological advantages, shows great potential in optimizing the reconstruction of human peripheral blood single nucleated cell (PBMC) model and immuno-oncology research.
Recently, InnoModels Biotechnology (Beijing) Co., Ltd. has made a major breakthrough in the field of pharmaceutical technology, and successfully obtained a patent entitled “Method and application for the detection of immune system rebuilding ability of PBMC”. This patent not only adds a new footnote to the R&D strength of InnoModels Biotechnology in the field of biomedicine, but also provides a strong technical support for the promotion of drug research and development and the establishment of humanized experimental animal models
With the rapid development of biotechnology, the in-depth study of the immune system has become the key to new drug discovery, disease diagnosis and treatment. InnoModels Bio-technology (Beijing) Co., Ltd. provides strong support for researchers with its profound scientific background and advanced technology platform. Among them, the ELISpot platform of InnoModels Biotechnology has made a name for itself in the field of immunology research with its high sensitivity and multi-functionality
InnoModels' ADCC platform plays a pivotal role in advancing cancer treatment, and its unique technological advantages and innovative concepts have brought about a far-reaching impact on the field of tumor immunotherapy. The following is a detailed introduction of how the platform promotes the advancement of cancer treatment
In the field of tumor immunotherapy, complement-dependent cytotoxicity (CDC), as an important therapeutic mechanism, is gradually showing its great potential and value. In order to explore this mechanism more deeply, with its profound accumulation in the field of oncology and tumor immunopharmacodynamics CRO services, InnoModels Biotechnology (Beijing) Co., Ltd. has launched the CDC in vitro immune-tumor cell co-culture killing experimental platform, which provides researchers with a powerful and precise tool to help innovate cancer treatment
Previous page
1
2
43
  • Tel 15010000264
  • E-mail limy@imodels.tech
  • Tel 13810723384
  • Top

InnoModels Biotechnology (Beijing) Co., Ltd.

TEL:15010000264        13810723384

Address:Building 14, Life Valley, Shuangying West Road, Changping District, Beijing

Chuangmo Biotechnology (Beijing) Co., Ltd. Beijing ICP 222*** 98-1 Website Construction: China Enterprise Power Beijing Second Branch Company

北京中因科技有限公司

创模生物科技(北京)有限公司